(Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis SBI Healthcare Opportunities Fund - G
Scheme Objective
CAGR
return of 15.4% since its launch. Ranked 34 in Sectoral
category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . NAV as on 9 Oct 25 ₹430.059 ↑ 2.17 (0.51 %) Net Assets (AUM) as on 31 Aug 2025 ₹3,963 Cr. Launch Date 31 Dec 2004 Category Equity - Sectoral Rating ☆☆ Type Open Ended Fund Risk High AMC SBI Funds Management Private Limited Alpha Ratio 2.04 Expense Ratio 1.97 % Sharpe Ratio -0.053 Information Ratio 0.38 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 9 Oct 25 Duration Returns 1 Month -0.7% 3 Month -1.1% 6 Month 9.3% 1 Year 1.4% 3 Year 25% 5 Year 18.7% 10 Year 15 Year Since launch 15.4% Historical Annual Returns
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% Growth of 10k Over Years
Date Value Asset Allocation
Asset Class Value Cash 3.85% Equity 96.15% Sector Allocation
Sector Value Health Care 90.36% Basic Materials 5.79% Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMADrug Manufacturers - Specialty & Generic 11% ₹431 Cr 2,700,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLABDrug Manufacturers - Specialty & Generic 7% ₹270 Cr 440,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | 543220Medical Care Facilities 6% ₹242 Cr 2,100,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | CIPLADrug Manufacturers - Specialty & Generic 5% ₹191 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3ADiagnostics & Research 4% ₹168 Cr 270,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | LUPINDrug Manufacturers - Specialty & Generic 4% ₹159 Cr 840,000 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 30 Jun 21 | TORNTPHARMDrug Manufacturers - Specialty & Generic 4% ₹142 Cr 400,000
↑ 80,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKINDDrug Manufacturers - Specialty & Generic 3% ₹138 Cr 560,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | FORTISMedical Care Facilities 3% ₹137 Cr 1,500,000 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLANDDrug Manufacturers - Specialty & Generic 3% ₹131 Cr 700,000
Talk to our investment specialistFund Managers
Name Since Tenure Tanmaya Desai 1 Jun 11 14.26 Yr. Custodians
Company Address Bank of Nova Scotia 12/13, Maker Chamber VI,220, Nariman Point HDFC Bank Ltd HDFC Bank House,Kamala Mills Compound,Senapati Bapat Marg,,Lower Parel (W), SBI-SG Global Securities Services Private Limited “B Wing”, “Jeevan Seva” Annexe Bldg.,Ground Floor, S.V. Road,Santacruz (W),,Mumbai – 400054 Registrar & Transfer Agent
Computer Age Management Services Ltd Address New No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam FAX 91-44-28283610 Email enq_L@camsonline.com Administrator Companies
Company Address SBI Mutual Fund 191"E", Maker Tower,Cuffe Parade Auditors
Company Address M/s. M. M. Nissim & Co. 3rdFloor, B Wing, Barodawala Mansion, 81,,Dr. Annie Besant Road, Worli, All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year SBI Healthcare Opportunities Fund
Growth ₹430.059
↑ 2.17 9.28 % 1.37 % 24.95 % 18.66 % SBI Healthcare Opportunities Fund
Normal Dividend, Reinvestment ₹272.972
↑ 2.06 9.28 % 1.37 % 24.95 % 18.66 % SBI Healthcare Opportunities Fund
Normal Dividend, Payout ₹272.972
↑ 2.06 9.28 % 1.37 % 24.95 % 18.66 % Data as on 10 Oct 25